<DOC>
	<DOCNO>NCT00567515</DOCNO>
	<brief_summary>This study evaluate acute long-term safety effectiveness Left atrial appendage occlusion ( LAA ) AtriCure LAA Occlusion System . This device apply patient atrial fibrillation ( AF ) , paroxysmal , persistent permanent , undergo cardiac surgery concomitant Maze/Ablation procedure .</brief_summary>
	<brief_title>Safety Effectiveness Left Atrial Appendage Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Documented history ( paroxysmal , persistent permanent ) AF [ one episode within last 12 month enrollment ] 2 . Elective Maze procedure 3 . Suitable anatomy 4 . Able willing sign inform consent 5 . Age 18 year 1 . Patient Intensive Care Unit either : 1. intravenous catecholamine 2. ventilator 3. cardiac index &lt; 1.8 l/min . 2 . Reoperative Cardiac Surgery 3 . Systemic Inflammatory disease 4 . Dialysis 5 . Recent myocardial infarction ( &lt; 21 day ) 6 . History pericarditis 7 . Patient take part device drug study 8 . Patient known sensitivity allergy device component 9 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>